Single-cell assessment of MRD. Multiomic evaluation of MRD at remission may provide not only the underlying clonal architecture but also the cellular state of each clone, potential cellular fates, and cell-cell ecosystems within the bone marrow environment. Comparing these observations with those from diagnosis and relapse and the patient’s eventual clinical outcome may provide valuable insight into the clinical significance of the detected MRD.